David I. Chemerow

CIK: 0001193743

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AIM

AIM ImmunoTech Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AIM
AIM ImmunoTech Inc.
Mar 12, 2026
Conversion(C)
Direct
25K shares-
AIM
AIM ImmunoTech Inc.
Mar 6, 2026
Other(J)
Series G Convertible Preferred Stock
Direct
25 shares at avg. $25000.00-
AIM
AIM ImmunoTech Inc.
Mar 6, 2026
Other(J)
Class G Warrants
Direct
50K shares-
AIM
AIM ImmunoTech Inc.
Feb 5, 2026
Award(A)
Indirect
2.8K shares at avg. $1.23$3K
AIM
AIM ImmunoTech Inc.
Mar 14, 2025
Award(A)
Direct
44.9K shares at avg. $0.12$5K
AIM
AIM ImmunoTech Inc.
Feb 28, 2025
Award(A)
Direct
19.3K shares at avg. $0.14$3K

		Type	Shares	Price		Ownership
Mar 12, 2026	AIM AIM ImmunoTech Inc.	Conversion(C)	25,000	-	$0	Direct
Mar 6, 2026	AIM AIM ImmunoTech Inc.	Other(J) Series G Convertible Preferred Stock	25	$25000.00	-	Direct
Mar 6, 2026	AIM AIM ImmunoTech Inc.	Other(J) Class G Warrants	50,000	-	-	Direct
Feb 5, 2026	AIM AIM ImmunoTech Inc.	Award(A)	2,800	$1.23	$3,444	Indirect
Mar 14, 2025	AIM AIM ImmunoTech Inc.	Award(A)	44,899	$0.12	$5,208	Direct
Feb 28, 2025	AIM AIM ImmunoTech Inc.	Award(A)	19,290	$0.14	$2,604	Direct

1-6 of 6 transactions

About CHEMEROW DAVID I.

CHEMEROW DAVID I. (SEC CIK 0001193743) files insider reports with the SEC as Director of AIM ImmunoTech Inc. (AIM).

Signal8 holds 6 ownership filings by CHEMEROW DAVID I. (1 Form 3, 5 Form 4), filed between Feb 26, 2025 and Mar 16, 2026. Those filings report 6 transactions, from Feb 28, 2025 to Mar 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CHEMEROW DAVID I.'s filings is in OCALA,, FL.

Recent filings by CHEMEROW DAVID I.

Mar 12, 2026: Conversion of AIM shares (Form 4, code C).
Mar 6, 2026: Other transactions of AIM derivative securities (2 lines, Form 4, code J).
Feb 5, 2026: Grant or award of AIM shares (Form 4, code A).
Mar 14, 2025: Grant or award of AIM shares (Form 4, code A).
Feb 28, 2025: Grant or award of AIM shares (Form 4, code A).

Other insiders filing for AIM ImmunoTech Inc. (AIM)

Equels Thomas K, CEO & President
KELLNER TED D, Director
MITCHELL WILLIAM M, Director
Rodino Peter W III, COO, Secretary, Gen. Counsel
BRYAN NANCY, Director
APPELROUTH STEWART, Director

How to read Form 4 transaction codes